CURRENT ISSUE Current Issue Cover
VOL 6 • NUMBER 3 MAY/JUN
IN THIS ISSUE

Communication of Bad News to Patients: Is Honesty the Best Policy?

Pamela Hallquist Viale, RN, MS, CS, ANP

The Consequences of a BRCA Mutation in Women

Janice Famorca-Tran, RN, MS, AOCNP®, CBCN®, NP-C, and Gayle Roux, PhD, NP-C, FAAN

The Toxicity and Benefit of Various Dosing Strategies for Interleukin-2 in Metastatic Melanoma and Renal Cell Carcinoma

Laura A. Pachella, RN, MSN, AGPCNP-BC, AOCNP®, Lydia T. Madsen, PhD, RN, AOCNS®, and Joyce E. Dains, DrPH, JD, RN, FNP-BC, DPNAP, FAANP

Hypnosis for the Management of Anticipatory Nausea and Vomiting

Kathy G. Kravits, MA, RN, HNB-BC, LPC, NCC, ATR-BC

More Articles More Articles
 
Section Seperator

TODAY'S NEWS

Molecular Classification of Glioma Based...

In a study reported in The New England Journal of ...

Chinese Study Finds Serum MicroRNA Class...

In a study reported in The Lancet Oncology, Lin et...

MASCC/ISOO 2015: Phase III Study of Sing...

Researchers from Merck presented results from a ph...

Better Outcome With Paclitaxel vs Nab-Pa...

In the phase III CALGB 40502/NCCTG N063H/Alliance ...

MASCC/ISOO 2015: Data Show Disconnect Be...

Data presented at the 2015 MASCC/ISOO Annual Meeti...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

Pembrolizumab for Treatment of Melanoma

Malignant melanoma accounts for only 2% of skin cancers, but it is the most deadly form of skin cancer...

Evaluating a Sexual Health Education Resource

This article shares the findings of an evaluation of a patient teaching resource for sexual health...

Significance of HPV in Head and Neck Cancers

Over 45,000 Americans are estimated to be newly diagnosed with cancer of the oral cavity and pharynx in 2015...

Cal/Mag to Prevent Neurotoxicity in Patients

A groundbreaking oral abstract was presented by Charles Loprinzi at the 2013 ASCO annual meeting...

Cal/Mag for Oxaliplatin-Induced Neurotoxicity

Neurotoxicity associated with chemotherapy continues to be of great concern to both APs in oncology and their patients...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

Dutch Study Indicates No Survival Benefi...

In a Dutch phase II study reported in <em>Th...

Phase II Trial Shows Activity of mTOR In...

In a randomized phase II trial reported in the <...

Survival Benefit of Surgery Lower for Lo...

In a population-based cohort study reported in <...

Differences in Patient-Reported Outcomes...

In a pooled analysis of the TEXT and SOFT trials r...

No Benefit of Adding CT to Basic Screeni...

In a Canadian study reported in <em>The New ...

More Highlights More Highlights
 
Section Seperator
Section Seperator
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer